India Diagnostic Imaging Market By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions, Mammography, Others), By Mobility (Portable, Standalone), By Source (Domestic, Import), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others), By Component (OEM, Refurbished), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Diagnostic Imaging Market was valued at USD 845.91 Million in 2024 and is expected to reach USD 1366.46 Million by 2030 with a CAGR of 8.28% during the forecast period.

Diagnostic imaging involves non-invasive techniques used to detect, monitor, and evaluate diseases or injuries by generating detailed images of the body. These methods help healthcare professionals accurately assess patient conditions and plan appropriate treatments.

Common technologies include X-ray for imaging bones and tissues, MRI for detailed visualization of internal structures, CT scans for cross-sectional imaging, and ultrasound for real-time imaging of organs. Nuclear imaging techniques such as PET scans further enable the analysis of metabolic activity. These advanced imaging modalities enhance diagnostic accuracy, support personalized treatment planning, and improve patient outcomes.

Download Free Sample Report

Key Market Drivers

Rise in the Prevalence of Chronic Diseases and Increased Adoption of Advanced Technologies in Medical Imaging

• India’s diagnostic imaging demand is rising because the country is carrying a much heavier chronic disease burden than it did a generation ago, and this directly increases the need for timely CT, MRI, PET, ultrasound, and digital X-ray examinations across oncology, cardiology, pulmonology, endocrinology, and musculoskeletal care.

• The Government of India has stated that the share of deaths caused by non communicable diseases rose from 37.9 percent in 1990 to 61.8 percent in 2016, while the national response has expanded to include 677 district level NCD clinics, 187 district cardiac care units, 266 district day care centres, and 5,392 NCD clinics at community health centre level, showing how disease pressure is already reshaping diagnostic infrastructure. This burden is intensifying because cancer, diabetes, heart disease, chronic respiratory disease, and age related bone disorders all require repeated imaging for screening, diagnosis, treatment planning, and follow up, and higher awareness among patients is pushing hospitals to invest in better image quality and quicker turnaround times.

• For instance, Siemens Healthineers said its India operations now include more than 3,900 employees and local manufacturing for both CT and MRI in Bengaluru under the government’s PLI framework, which is a strong signal that major imaging companies see sustained and widening demand from India’s chronic care pathway rather than only from premium urban hospitals.

Increased Adoption of Advanced Technologies in Medical Imaging

• India’s diagnostic imaging ecosystem is moving beyond basic scan availability and toward more sophisticated systems that improve speed, consistency, image quality, and workflow efficiency, which is why technologies such as digital radiography, multi-slice CT, helium-free MRI platforms, AI-enabled reconstruction, and portable ultrasound are gaining stronger acceptance across hospitals and diagnostic chains.

• This shift matters because advanced platforms help clinicians detect disease earlier, assess organ function more clearly, reduce repeat scans, and manage larger patient volumes without compromising diagnostic confidence, which is especially important in a market where specialist radiology capacity is still unevenly distributed across metro and non-metro centres.

• Government-backed manufacturing policies are also helping accelerate this transition, since local production lowers dependence on imports, supports faster deployment, and encourages vendors to design equipment for Indian clinical settings, including facilities with space, cost, and infrastructure constraints. Major manufacturers are now aligning their India strategy with these needs by localizing production and introducing platforms that emphasize operational productivity as much as clinical performance, making advanced imaging more practical for second-tier and third-tier cities.

• For instance, Wipro GE Healthcare said its Made in India Revolution Aspire CT, produced at its domestic plant backed by an investment of a little over Rs 100 crore, can deliver up to 50 percent higher patient throughput, underscoring how technology adoption in India is increasingly tied to scale, workflow efficiency, and wider geographic access rather than only to premium innovation.

Growing Geriatric Population

• India’s aging population is becoming a major structural driver for diagnostic imaging because older adults face a much higher risk of hypertension, diabetes, stroke, chronic lung disease, arthritis, osteoporosis, dementia, and cancer, all of which require imaging not just for first diagnosis but also for long term monitoring and treatment decisions. Government data shows that the population aged 60 years and above is projected to rise from 100 million in 2011 to 230 million by 2036, which means nearly one in seven Indians will be an older adult, and that demographic transition will steadily increase demand for chest imaging, brain scans, vascular imaging, oncology screening, and musculoskeletal assessments.

• This is especially relevant for India because elderly patients often need repeat and lower stress imaging pathways, so hospitals are under pressure to adopt systems that are easier to install, more efficient to run, and better suited for continuous service delivery across both large cities and emerging regional care centres. Better healthcare awareness and expanding public and private investment are also improving the likelihood that seniors seek diagnostic care earlier, which can reduce complications and support more effective disease management over time.

• For instance, Philips announced in India that it had already achieved more than 1,500 installations worldwide of its helium-free 1.5T wide-bore MRI platform and launched its AI-enabled CT 5300 for the Indian market, illustrating how major imaging companies are positioning elder-friendly, workflow-oriented technologies for a country where the senior population is set to expand sharply.

Rising Demand for The Early Detection of Diseases

• The push for early disease detection is becoming one of the clearest growth drivers for imaging in India because doctors and health systems increasingly recognize that earlier identification of cancer, diabetes linked complications, cardiovascular conditions, respiratory disorders, fractures, and abdominal disease can sharply improve treatment planning and reduce downstream clinical burden.

• India’s policy framework is also moving in this direction, as the government has rolled out a population-based initiative for prevention, control, and screening of common NCDs and specifically targets people above 30 years of age for screening under Ayushman Bharat Health and Wellness Centres, which expands the funnel of patients who may require confirmatory or follow up imaging after initial risk assessment.

• This makes CT, MRI, ultrasound, and digital X ray increasingly central to preventive care because clinicians need fast, reliable, and scalable tools to investigate suspicious symptoms before disease progresses to a more expensive or less treatable stage. Rising health awareness, broader diagnostic expectations, and stronger public-private participation are reinforcing this shift, particularly as India tries to narrow the urban-rural gap in access to quality diagnostics without sacrificing productivity or scan quality.

• For instance, Siemens Healthineers said its MAGNETOM Free. Star is now manufactured in Bengaluru and designed as a virtually helium free MRI with an ultra compact footprint that is easier to install, a useful example of how companies are tailoring advanced imaging platforms to support earlier diagnosis in Indian facilities that need both clinical sophistication and practical deployment flexibility.

Key Market Challenges

High Cost of Diagnostic Imaging Procedures and Equipment

• High cost remains a major constraint on the India diagnostic imaging market because advanced modalities such as MRI, CT, and digital radiology require expensive equipment, shielding infrastructure, installation, maintenance, trained manpower, and periodic quality assurance. These combined cost layers raise the financial burden for both imaging providers and patients seeking access.

• These economics are especially difficult outside metropolitan areas because imaging facilities need licensed installations, radiation shielding, qualified operators, and approved quality systems before they can begin operations. This increases entry barriers for new diagnostic centers and slows capacity expansion in smaller cities and underserved regions across India.

• The affordability burden is even sharper for lower-income patients, many of whom delay scans unless the procedure is medically urgent, which weakens early diagnosis and routine disease monitoring. Although public schemes are helping, reimbursement still does not fully offset affordability pressure for private providers investing in premium imaging systems. For instance, the Ayushman Bharat Health Benefit Package lists high-end radiological diagnostics including CT, MRI, and nuclear imaging at "Rs " 5,800, showing how tightly cost sensitivity influences access in this category.

Side Effects of Diagnostic Imaging Procedures

• Concerns about side effects from diagnostic imaging procedures remain a challenge for the India diagnostic imaging market, especially because cumulative radiation exposure from CT scans and repeated X-rays can influence patient confidence and raise provider obligations around safety management, clinical justification, and communication before conducting imaging procedures.

• While radiation-based imaging remains indispensable for accurate diagnosis and treatment planning, these modalities must operate within a strict safety framework involving licensing, shielding, trained personnel, and regular quality checks. This reinforces the need for imaging to be justified, optimized, and carefully monitored, particularly in cases involving repeat scans or vulnerable patient groups.

• As a result, imaging centers must invest not only in advanced equipment but also in compliance systems, safety oversight, and patient communication so scans are viewed as necessary and controlled rather than casually administered. For instance, AERB requires periodic quality assurance of diagnostic X-ray equipment at least once every two years and mandates that every CT installation have a qualified radiologist and an approved Radiation Safety Officer, highlighting the seriousness of radiation risk management in India.

Key Market Trends

Growing Expenditure in The Healthcare Sector

• Growing expenditure in the healthcare sector is directly strengthening the India diagnostic imaging market because higher public spending, broader insurance-supported care delivery, and continued hospital expansion are improving the ability of healthcare providers to procure, install, and utilize advanced CT, MRI, ultrasound, and nuclear imaging systems across different levels of care.

• Imaging demand rises sharply when more patients enter formal treatment pathways for cancer, cardiovascular disease, neurological disorders, trauma, and chronic metabolic conditions that require repeated scans for screening, diagnosis, treatment planning, and follow-up. This makes rising healthcare expenditure an important structural driver of long-term demand for diagnostic imaging equipment and services in India.

• Increased funding is also supporting modernization of tertiary hospitals, research institutions, and specialty centers, which is encouraging adoption of better image quality, faster workflow, and digitally integrated radiology systems in both public and private settings. As healthcare infrastructure expands, diagnostic imaging is becoming a more central part of routine clinical decision-making rather than a limited urban capability. For instance, the Government of India reported government health expenditure of "Rs " 4,34,163" crore"  in 2021 to 2022, while Siemens Healthineers committed "Rs " 1,300" crore"  over five years for an India innovation hub combining R&D and medical imaging manufacturing.

Increasing Adoption of Latest Technologies in Diagnostic Imaging Equipment

• India is seeing stronger adoption of the latest diagnostic imaging technologies as hospitals, diagnostic centers, and imaging chains focus not only on adding scan capacity, but also on improving speed, accuracy, workflow efficiency, and access to quality diagnostics beyond major metropolitan areas. This is making technology upgrades a core growth trend in the India diagnostic imaging market.

• Providers are increasingly interested in AI-enabled CT, digitally optimized imaging systems, and locally manufactured platforms because these technologies can help manage high patient volumes while improving clinical confidence and reducing operational bottlenecks. In India, where radiology access and specialist availability remain uneven, equipment productivity and reliability are often just as important as image quality.

• Policy support for domestic medical device manufacturing is further accelerating this trend by encouraging companies to design and produce imaging systems inside India that better match local affordability, infrastructure, and accessibility needs. This is especially relevant for expanding diagnostic access in smaller cities. For instance, Wipro GE Healthcare’s Revolution Aspire CT was designed and manufactured end to end in India at a plant that is one of 15 medical device manufacturing units approved under the government’s PLI scheme, with the company specifically positioning the system to expand access across tier 2 and tier 3 cities.

Segmental Insights

Type Insights

Based on the type, in 2024, The ultrasound systems segment has emerged as the largest market share holder within the medical imaging industry, a position driven by the growing adoption of ultrasound equipment in the healthcare sector. The segment’s dominance can be attributed to the affordability, advanced features, and user-friendly nature of ultrasound technology. Its ability to deliver instant and precise results, coupled with safety advantages such as radiation-free imaging and non-invasive procedures, has made ultrasound one of the most widely utilized diagnostic tools in India. These factors have firmly established ultrasound as a leading segment in the medical imaging market.

Application Insights

Based on the application, the oncology segment dominated the global diagnostic imaging market in 2024, in terms of revenue, and is projected to sustain its dominance during the forecast period. This can be attributed to the increased prevalence of cancer among the population, particularly with lung cancer being the most prominent type and accounting for the highest number of cancer deaths in India. Remarkably, according to the International Agency for Research on Cancer, breast cancer has now surpassed lung cancer as the most diagnosed type of cancer. As a result, the demand for oncology diagnostic imaging has experienced a significant surge, contributing to the growth of this segment.

Download Free Sample Report

Regional Insights

The western region of India, especially Maharashtra, is a key leader in the country’s diagnostic imaging market. Its growth is fueled by advanced healthcare infrastructure, including state-of-the-art hospitals and cutting-edge medical facilities equipped with the latest imaging technologies, enabling precise and efficient diagnoses.

High health awareness among the population drives strong demand for diagnostic imaging services, which is met by major providers and manufacturers with a broad range of solutions tailored to local needs.

Maharashtra’s continuous focus on innovation, technological adoption, and healthcare excellence positions it to maintain its dominance in India’s diagnostic imaging market and act as a catalyst for further industry growth.

Recent Developments

• In February 2026, FUJIFILM India unveiled four new diagnostic imaging and healthcare IT solutions at IRIA 2026, including the FCT iStream CT platform, AMULET SOPHINITY digital mammography, FDR Smart X Essential digital radiography, and the HCIT Fenix ecosystem. The company said these launches were designed to help radiology departments handle rising imaging volumes, workforce constraints, and growing diagnostic complexity, making the rollout one of the clearest recent product expansions in India’s imaging market.

• In October 2025, Philips expanded its collaboration with Nicolab to advance stroke care in India by combining Philips’ imaging systems with Nicolab’s StrokeViewer AI platform. The partnership was framed as a way to improve stroke diagnosis and treatment workflows in India by linking real-time high-resolution imaging with AI-assisted interpretation for faster clinical decision-making.

• In July 2025, Mahajan Imaging & Labs launched India’s first AI-powered ultra-fast MRI at its new Dwarka centre in Delhi through the debut of the Excel 3T MRI scanner. The company said the scanner delivered up to 50% better signal-to-noise ratio and could shorten complex cardiac MRI scan times to about 30-40 minutes, while the centre also added AI-enabled ultrasound, cardiac CT, mammography, digital X-ray, and bone densitometry as part of a broader integrated imaging ecosystem.

• In March 2025, India’s first indigenous MRI machine was reported as having been developed and scheduled for installation at AIIMS Delhi for trials, marking a major domestic breakthrough in high-end diagnostic imaging technology. The development was positioned as an important step toward reducing dependence on imported MRI systems while strengthening local innovation capacity in advanced radiology equipment.

Key Market Players

• Wipro GE Healthcare Private Limited
• Siemens Healthineers India
• Allengers Medical Systems Limited
• Erbis Engineering Co Limited
• Samsung India Electronics (SIEL)
• Philips India Limited
• Olympus Medical Systems India Private Limited
• Fujifilm India Private Limited
• Carestream Health India Private Limited
• Shimadzu Medicals (India) Private Limited

Report Scope:

In this report, the India Diagnostic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Diagnostic Imaging Market, By Type:

o   X-Ray Imaging Solutions

o   Ultrasound Systems

o   MRI Systems

o   CT Scanner

o   Nuclear Imaging Solutions

o   Mammography

o   Others

• India Diagnostic Imaging Market, By Mobility:

o   Portable

o   Standalone

• India Diagnostic Imaging Market, By Source:

o   Domestic

o   Import

• India Diagnostic Imaging Market, By Application:

o   Cardiology

o   Oncology

o   Neurology

o   Orthopedics

o   Gastroenterology

o   Gynecology

o   Others

• India Diagnostic Imaging Market, By Component:

o   OEM

o   Refurbished

• India Diagnostic Imaging Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Ambulatory Care Centers

o   Others

• India Diagnostic Imaging Market, By Region:

o   North India

o   South India

o   West India

o   East India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Diagnostic Imaging Market.

Available Customizations:

India Diagnostic Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Diagnostic Imaging Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]